NCT01457690View on ClinicalTrials.gov

Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterolemia With Chylomicron Retention

PHASE3CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Hypobetalipoproteinemias
Interventions
DRUG

Tocofersolan

Administration of a daily dose of vitamin E for 4 months:50 IU/kg

DRUG

tocopherol alpha

Administration of a daily dose of vitamin E for 4 months:50 IU/kg

DRUG

Tocofersolan and tocopherol alpha

Administration of a single dose of vitamin E (Vitamin E water-soluble then Vitamin E conventional fat-soluble form)

Trial Locations (1)

69677

Hopital Femme Mere Enfant-Hospices Civils de Lyon, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT01457690 - Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterolemia With Chylomicron Retention | Biotech Hunter | Biotech Hunter